1. Home
  2. PRTA vs VPG Comparison

PRTA vs VPG Comparison

Compare PRTA & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • VPG
  • Stock Information
  • Founded
  • PRTA 2012
  • VPG 2009
  • Country
  • PRTA Ireland
  • VPG United States
  • Employees
  • PRTA N/A
  • VPG N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • VPG Electrical Products
  • Sector
  • PRTA Health Care
  • VPG Technology
  • Exchange
  • PRTA Nasdaq
  • VPG Nasdaq
  • Market Cap
  • PRTA 472.1M
  • VPG 340.4M
  • IPO Year
  • PRTA N/A
  • VPG N/A
  • Fundamental
  • Price
  • PRTA $8.20
  • VPG $28.45
  • Analyst Decision
  • PRTA Buy
  • VPG
  • Analyst Count
  • PRTA 10
  • VPG 0
  • Target Price
  • PRTA $14.86
  • VPG N/A
  • AVG Volume (30 Days)
  • PRTA 1.2M
  • VPG 103.9K
  • Earning Date
  • PRTA 08-04-2025
  • VPG 08-05-2025
  • Dividend Yield
  • PRTA N/A
  • VPG N/A
  • EPS Growth
  • PRTA N/A
  • VPG N/A
  • EPS
  • PRTA N/A
  • VPG N/A
  • Revenue
  • PRTA $10,341,000.00
  • VPG $295,282,000.00
  • Revenue This Year
  • PRTA N/A
  • VPG N/A
  • Revenue Next Year
  • PRTA $389.77
  • VPG $5.48
  • P/E Ratio
  • PRTA N/A
  • VPG N/A
  • Revenue Growth
  • PRTA N/A
  • VPG N/A
  • 52 Week Low
  • PRTA $4.32
  • VPG $18.57
  • 52 Week High
  • PRTA $22.83
  • VPG $30.11
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 58.73
  • VPG 54.91
  • Support Level
  • PRTA $8.05
  • VPG $28.22
  • Resistance Level
  • PRTA $8.73
  • VPG $29.81
  • Average True Range (ATR)
  • PRTA 0.38
  • VPG 0.87
  • MACD
  • PRTA -0.05
  • VPG 0.15
  • Stochastic Oscillator
  • PRTA 47.62
  • VPG 62.29

About PRTA Prothena Corporation plc

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

Share on Social Networks: